首页|期刊导航|中西医结合肝病杂志|祛湿化瘀方治疗MCD饮食诱导的代谢功能障碍相关脂肪性肝炎小鼠的药效观察

祛湿化瘀方治疗MCD饮食诱导的代谢功能障碍相关脂肪性肝炎小鼠的药效观察OA

Pharmacological effects of Qushi Huayu formula in improving MCD diet-induced metabolic dysfunction-associated steatohepatitis in mice

中文摘要英文摘要

目的:探讨祛湿化瘀方(QSHY)对蛋氨酸胆碱缺乏(MCD)饮食诱导的代谢功能障碍相关脂肪性肝炎(MASH)模型小鼠的干预作用.方法:将24只小鼠随机分为蛋氨酸胆碱充足(MCS)饮食组6只,MCD饮食造模组18只.造模3周末,将MCD饮食造模组小鼠随机分为MCD组、MCD+QSHY组和MCD+奥贝胆酸(OCA)组,每组6只,分别给予相应药物或饮用水灌胃4周后取材,观察各组小鼠一般情况;检测肝组织甘油三酯(TG)含量,血清丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、TG水平;苏木精-伊红(HE)染色、油红O染色、天狼猩红染色观察肝组织病理学改变;实时荧光定量聚合酶链反应(qRT-PCR)检测肝脏组织中脂质合成相关基因脂肪酸合酶(FASN)和甾醇调节元件结合转录因子1(SREBF-1),炎症细胞因子肿瘤坏死因子α(TNF-α)、白细胞介素(IL)-1β、IL-6,纤维化标志物Ⅰ型胶原蛋白α1链(COL1A1)、肌动蛋白α2(ACTA2)mRNA表达水平.结果:与MCS组相比,MCD组小鼠肝组织TG表达水平显著升高(P<0.01),血清TG表达水平显著降低(P<0.001),血清ALT、AST水平显著升高(P<0.001),油红O染色可见大量红色脂滴沉积,HE染色显示MCD组小鼠肝组织形成大量脂肪空泡及炎性细胞浸润,天狼猩红染色显示胶原增生明显,PCR结果显示,肝组织FASN、SREBF-1、TNF-α、IL-1β、IL-6以及COL1A1、ACTA2 mRNA表达水平均显著高于MCS组(P<0.01).与MCD组相比,MCD+QSHY组和MCD+OCA组小鼠肝组织TG表达水平均显著下降(P<0.05),MCD+QSHY组血清TG显著升高(P<0.001),两组小鼠血清ALT、AST水平显著降低(P<0.05),油红O染色显示MCD+QSHY组及MCD+OCA组小鼠肝细胞脂质沉积明显改善,HE结果显示QSHY及OCA可显著改善肝组织脂肪变性、减轻炎症,天狼猩红染色显示两组小鼠肝组织胶原沉积均明显减少,PCR结果显示,肝组织 FASN、SREBF-1、TNF-α、IL-6、COL1A1、ACTA2 mRNA 表达水平均显著降低(P<0.05).结论:QSHY 对 MCD 饮食诱导的MASH小鼠具有明显改善作用,主要表现为减轻肝脏脂肪沉积及病理损伤,抑制炎症反应和纤维化.

Objective:To investigate the effects of Qushi Huayu formula(QSHY)on a methionine-choline deficient(MCD)diet-induced mouse model of metabolic dysfunction-associated steatohepatitis(MASH).Methods:Twenty-four mice were randomly divided into two groups:the methionine-choline sufficient(MCS)diet group(n=6)and the MCD diet model group(n=18).At the end of 3 weeks of modeling,the MCD diet-fed mice were further randomized into three groups:MCD group,MCD+QSHY group,and MCD+obeticholic acid(OCA)group.The mice received corresponding drug treatments or vehicle via oral gavage for 4 weeks before sample collection.General conditions of the mice were observed;liver triglyceride(TG)content and serum Alanine Aminotransferase(ALT)、Aspartate Aminotransferase(AST)levels were measured.Hepatic histopathological changes were evaluated using H&E staining,Oil Red O staining,and Sirius red staining.The mRNA expression levels of genes related to lipid synthesis(Fatty Acid Synthase[FASN],Sterol Regulatory Element Binding Transcription Factor 1[SREBF-1]),inflammation(Tumor Necrosis Factor-α[TNF-α],Interleukin[IL]-1β,IL-6),and fibrosis(Collagen Type Ⅰ Alpha 1[COL1A1],Actin Alpha 2 Smooth Muscle[ACTA2])were detected by quantitative real-time polymerase chain reaction(qRT-PCR).Results:Compared with the MCS group,the MCD group exhibited significantly increased hepatic TG content(P<0.01),decreased serum TG content(P<0.001),and significantly elevated serum ALT and AST levels(P<0.001).Oil Red O staining revealed extensive lipid droplet accumulation in the liver,while H&E staining showed prominent hepatic steatosis and inflammatory cell infiltration.Sirius Red staining demonstrated obvious collagen deposition.qRT-PCR analysis showed that the mRNA expression levels of the lipogenesis-related genes FASN and SREBF-1,the inflammatory cytokines TNF-α,IL-1β and IL-6,as well as the fibrosis-related genes COL1A1 and ACTA2 were significantly increased(P<0.01).Compared with the MCD group,both the MCD+QSHY and MCD+OCA groups exhibited significantly reduced hepatic TG content(P<0.05),while serum TG levels were significantly increased in the MCD+QSHY group(P<0.001).Serum ALT and AST levels were markedly decreased in both treatment groups(P<0.05).Oil Red O staining showed markedly reduced hepatic lipid accumulation following QSHY or OCA treatment.H&E staining showed that both interventions alleviated hepatic steatosis and inflammatory infiltration,while Sirius Red staining revealed markedly reduced collagen deposition.Furthermore,both treatments downregulated the expression of FASN,SREBF-1,TNF-α,IL-6,COL1A1,and ACTA2(P<0.05).Conclusion:Qushi Huayu Formula exhibits significant ameliorative effects on MASH mice induced by MCD diet,reducing hepatic lipid accumulation and pathological damage in liver tissue while suppressing liver inflammation and fibrosis.

于楚楚;潘雨晴;毛傲洁;赵瑜;胡义扬;刘巧红

上海中医药大学附属曙光医院肝病研究所(上海,201203)上海中医药大学附属曙光医院肝病研究所(上海,201203)上海中医药大学附属曙光医院肝病研究所(上海,201203)上海中医药大学附属曙光医院肝病研究所(上海,201203)||肝肾疾病病证教育部重点实验室||上海市中医临床重点实验室上海中医药大学附属曙光医院肝病研究所(上海,201203)||肝肾疾病病证教育部重点实验室||上海市中医临床重点实验室||上海中医药大学附属曙光医院临床研究中心上海中医药大学附属曙光医院临床研究中心

医药卫生

祛湿化瘀方蛋氨酸胆碱缺乏代谢功能障碍相关脂肪性肝炎

Qushi Huayu formulamethionine-choline deficientmetabolic dysfunction-associated steatohepatitis

《中西医结合肝病杂志》 2026 (8)

967-972,6

国家自然科学基金资助项目(No.82204840,82174186),上海市科学技术委员会扬帆计划(No.22YF1449400)

10.3969/j.issn.1005-0264.2026.008.005

评论